DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
-10.83%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$101M
AUM Growth
+$101M
(-15%)
Cap. Flow
-$10.8M
Cap. Flow
% of AUM
-10.73%
Top 10 Holdings %
Top 10 Hldgs %
44.39%
Holding
98
New
22
Increased
10
Reduced
28
Closed
10
Top Buys
| 1 |
NEOS
Neos Therapeutics, Inc
NEOS
|
$1.33M |
| 2 |
Adverum Biotechnologies
ADVM
|
$1.16M |
| 3 |
WINT
Windtree Therapeutics Inc
WINT
|
$814K |
| 4 |
VTAE
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
|
$780K |
| 5 |
Indaptus Therapeutics
INDP
|
$756K |
Top Sells
| 1 |
ZGNX
Zogenix, Inc.
ZGNX
|
$10.6M |
| 2 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$2.03M |
| 3 |
Gyre Therapeutics
GYRE
|
$1.83M |
| 4 |
EVFM
Evofem Biosciences, Inc. Common Stock
EVFM
|
$1.66M |
| 5 |
AtriCure
ATRC
|
$1.33M |
Sector Composition
| 1 | Healthcare | 73.41% |
| 2 | Financials | 0.2% |
